Michael Gralinski - Concepedia

Author

Michael Gralinski

Also Known As

Gralinski, Gralinski, Michael R., M R Gralinski, M. Gralinski, M. R Gralinski, M. R. Gralinski, Michael R. Gralinski, Michael Gralinski, Michael R Gralinski, Michael R. Gralinski

Publications

893

Citations

H-Index

Concepts

All Affiliations

University of Michigan Intuitive Surgical (United States)AngioDynamics (United States)Main Line Health Prisma

About

Michael Gralinski is an author at University of Michigan specializing in medicine, pharmacology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	338
2	Anesthesia	2	2	48
3	Public Health	1	1	37
4	Biochemistry	1	1	19
5	Cell Biology	1	1	41

Michael Gralinski

Publications

704

Citations

H-Index

Page 1

	Year	Citations
Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart Michael Gralinski, Simon Black, Kenneth S. Kilgore, Cardiovascular Research	1994	95
Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Gregory S. Friedrichs, Kenneth S. Kilgore, Peter J. Manley, Circulation Research Heparin PretreatmentCardiovascular PharmacologyIschemia/reperfusion-induced AlterationsAcute Myocardial InfarctionThrombosis	1994	85
Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury Simon Black, Michael Gralinski, Gregory S. Friedrichs, Cardiovascular Research	1995	82
Characterization of binding, functional activity, and contractile responses of the selective 5‐HT<sub>1F</sub> receptor agonist lasmiditan Eloísa Rubio‐Beltrán, Alejandro Labastida‐Ramírez, Kristian Agmund Haanes, British Journal of Pharmacology	2019	71
Effects of Troglitazone and Pioglitazone on Cytokine-Mediated Endothelial Cell Proliferation In Vitro Michael Gralinski, Paul E. Rowse, Michael A. Breider Journal of Cardiovascular Pharmacology InflammationCytokineAngiogenesisEndothelial CellsMedicine	1998	41
C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats David A. Zopf, Liomar A. A. Neves, Kristen J. Nikula, European Journal of Pharmacology HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseMedicine	2011	37
The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period Daniel J. Cushing, Warren D. Cooper, Michael Gralinski, Clinical and Experimental Pharmacology and Physiology Animal PhysiologyHypertensionHeart FailureMaintenance Infusion PeriodIntravenous Amiodarone	2009	35
Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart Michael Gralinski, Liguo Chi, James L. Park, Journal of Cardiovascular Pharmacology and Therapeutics	1996	31
Selective inhibition of the alternative complement pathway by sCR1[desLHR-a]protects the rabbit isolated heart from human complement-mediated damage Michael Gralinski, Bridget C. Wiater, Amy N. Assenmacher, Immunopharmacology Complement SystemAutoimmune DiseasePhysiologyImmunologyHuman Complement-mediated Damage	1996	30
Effect of Ranolazine on Infarct Size in a Canine Model of Regional Myocardial Ischemia/Reperfusion Shawn C. Black, Michael Gralinski, James G. McCormack, Journal of Cardiovascular Pharmacology	1994	30

Page 1